
David Guzo
Examiner (ID: 2124)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1805, 1636, 2899 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6361371
[patent_doc_number] => 20020058637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Methods of inhibiting tau-protein kinase I activity, inhibiting neuronal cell death and treating alzheimer\'s disease and tau-protein kinase I'
[patent_app_type] => new
[patent_app_number] => 09/866712
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8975
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09866712
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/866712 | Methods of inhibiting tau-protein kinase I activity, inhibiting neuronal cell death and treating alzheimer's disease and tau-protein kinase I | May 29, 2001 | Abandoned |
Array
(
[id] => 5726793
[patent_doc_number] => 20060057553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Chimeric viral vectors for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/297341
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30191
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297341
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297341 | Chimeric viral vectors for gene therapy | May 29, 2001 | Abandoned |
| 09/856659 | Novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors | May 22, 2001 | Abandoned |
Array
(
[id] => 5016220
[patent_doc_number] => 20070259429
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2007-11-08
[patent_title] => 'Adenoviral vectors having a protein IX deletion'
[patent_app_type] => utility
[patent_app_number] => 09/860211
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16583
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0259/20070259429.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860211
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860211 | Adenoviral vectors having a protein IX deletion | May 17, 2001 | Abandoned |
Array
(
[id] => 6860526
[patent_doc_number] => 20030091534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Adenoviral vectors having a protein IX deletion'
[patent_app_type] => new
[patent_app_number] => 09/860286
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16752
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091534.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860286 | Adenoviral vectors having a protein IX deletion | May 17, 2001 | Abandoned |
Array
(
[id] => 5016220
[patent_doc_number] => 20070259429
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2007-11-08
[patent_title] => 'Adenoviral vectors having a protein IX deletion'
[patent_app_type] => utility
[patent_app_number] => 09/860211
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16583
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0259/20070259429.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860211
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860211 | Adenoviral vectors having a protein IX deletion | May 17, 2001 | Abandoned |
Array
(
[id] => 6860526
[patent_doc_number] => 20030091534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Adenoviral vectors having a protein IX deletion'
[patent_app_type] => new
[patent_app_number] => 09/860286
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16752
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091534.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860286 | Adenoviral vectors having a protein IX deletion | May 17, 2001 | Abandoned |
Array
(
[id] => 1439342
[patent_doc_number] => 06495132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-17
[patent_title] => 'Method for producing polypeptides'
[patent_app_type] => B2
[patent_app_number] => 09/859773
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6544
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495132.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859773
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859773 | Method for producing polypeptides | May 16, 2001 | Issued |
| 09/600766 | Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein | May 13, 2001 | Abandoned |
Array
(
[id] => 6711564
[patent_doc_number] => 20030171313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Compositions and methods for treatment of hepatitis C virus-associated diseases'
[patent_app_type] => new
[patent_app_number] => 09/853409
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13101
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171313.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853409
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853409 | Compositions and methods for treatment of hepatitis C virus-associated diseases | May 10, 2001 | Issued |
Array
(
[id] => 6594421
[patent_doc_number] => 20020042134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Modification of bacteria'
[patent_app_type] => new
[patent_app_number] => 09/851419
[patent_app_country] => US
[patent_app_date] => 2001-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8422
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042134.pdf
[firstpage_image] =>[orig_patent_app_number] => 09851419
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/851419 | Modification of bacteria | May 8, 2001 | Issued |
Array
(
[id] => 7015052
[patent_doc_number] => 20010051605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-13
[patent_title] => 'Epidermal growth factor inhibitor'
[patent_app_type] => new
[patent_app_number] => 09/850373
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6903
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20010051605.pdf
[firstpage_image] =>[orig_patent_app_number] => 09850373
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/850373 | Epidermal growth factor inhibitor | May 6, 2001 | Abandoned |
Array
(
[id] => 7363878
[patent_doc_number] => 20040091866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation'
[patent_app_type] => new
[patent_app_number] => 10/258930
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7523
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091866.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258930
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258930 | Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation | Apr 29, 2001 | Issued |
Array
(
[id] => 6947890
[patent_doc_number] => 20010021524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-13
[patent_title] => 'Viral-mediated gene transfer system'
[patent_app_type] => new
[patent_app_number] => 09/842941
[patent_app_country] => US
[patent_app_date] => 2001-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6653
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20010021524.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842941
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842941 | Viral-mediated gene transfer system | Apr 25, 2001 | Abandoned |
Array
(
[id] => 7459906
[patent_doc_number] => 20040052764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids'
[patent_app_type] => new
[patent_app_number] => 10/257961
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13551
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257961
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257961 | Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids | Apr 22, 2001 | Issued |
Array
(
[id] => 1172080
[patent_doc_number] => 06750043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-15
[patent_title] => 'Viral vectors having reduced virulence'
[patent_app_type] => B2
[patent_app_number] => 09/837998
[patent_app_country] => US
[patent_app_date] => 2001-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2137
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750043.pdf
[firstpage_image] =>[orig_patent_app_number] => 09837998
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/837998 | Viral vectors having reduced virulence | Apr 18, 2001 | Issued |
Array
(
[id] => 6893981
[patent_doc_number] => 20010016347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-23
[patent_title] => 'Non-primate lentiviral vectors and packaging systems'
[patent_app_type] => new
[patent_app_number] => 09/837644
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23292
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20010016347.pdf
[firstpage_image] =>[orig_patent_app_number] => 09837644
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/837644 | Lentiviral nucleic acids and uses thereof | Apr 16, 2001 | Issued |
Array
(
[id] => 6032855
[patent_doc_number] => 20020019031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Chinese hamster ovary cells for producing proteins'
[patent_app_type] => new
[patent_app_number] => 09/835089
[patent_app_country] => US
[patent_app_date] => 2001-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3200
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019031.pdf
[firstpage_image] =>[orig_patent_app_number] => 09835089
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/835089 | Chinese hamster ovary cells for producing proteins | Apr 12, 2001 | Abandoned |
Array
(
[id] => 5786927
[patent_doc_number] => 20020160357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Differentiation of avian infectious bronchitis virus serotypes'
[patent_app_type] => new
[patent_app_number] => 09/829250
[patent_app_country] => US
[patent_app_date] => 2001-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7782
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160357.pdf
[firstpage_image] =>[orig_patent_app_number] => 09829250
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/829250 | Differentiation of avian infectious bronchitis virus serotypes | Apr 8, 2001 | Abandoned |
Array
(
[id] => 6884676
[patent_doc_number] => 20010038836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-08
[patent_title] => 'Application of myeloid-origin cells to the nervous system'
[patent_app_type] => new
[patent_app_number] => 09/825713
[patent_app_country] => US
[patent_app_date] => 2001-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 7854
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20010038836.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825713
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825713 | Application of myeloid-origin cells to the nervous system | Apr 3, 2001 | Abandoned |